Alyeska Investment Group, L.P. Maravai Lifesciences Holdings, Inc. Transaction History

Alyeska Investment Group, L.P.

$25.4 Billion
Q2 2025

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.42 - $8.5 $14 Million - $26.9 Million	3,161,072 Added 145.78%	5,329,420 $29 Million
Q3 2024 Nov 14, 2024	BUY	$6.84 - $9.73 $30,540 - $43,444	4,465 Added 0.21%	2,168,348 $18 Million
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $188,196 - $310,647	27,394 Added 1.28%	2,163,883 $15.5 Million
Q1 2024 May 15, 2024	SELL	$5.11 - $8.76 $5.42 Million - $9.29 Million	-1,060,000 Reduced 33.16%	2,136,489 $18.5 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $3.39 Million - $7.11 Million	720,742 Added 29.11%	3,196,489 $20.9 Million
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $8.36 Million - $10.4 Million	691,686 Added 38.77%	2,475,747 $30.8 Million
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $6.95 Million - $8.82 Million	535,242 Added 42.86%	1,784,061 $25 Million
Q4 2022 Feb 14, 2023	SELL	$12.5 - $24.78 $4.51 Million - $8.94 Million	-360,753 Reduced 22.41%	1,248,819 $17.9 Million
Q3 2022 Nov 14, 2022	BUY	$20.6 - $30.37 $12.1 Million - $17.8 Million	586,041 Added 57.26%	1,609,572 $41.1 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $3.84 Million - $5.52 Million	147,384 Added 16.82%	1,023,531 $29.1 Million
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $10.7 Million - $17.8 Million	436,101 Added 99.1%	876,147 $30.9 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $11.6 Million - $19.2 Million	316,282 Added 255.55%	440,046 $21.6 Million
Q1 2021 May 17, 2021	SELL	$25.8 - $38.49 $24.2 Million - $36.1 Million	-936,644 Reduced 88.33%	123,764 $4.41 Million
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $26 Million - $32.7 Million	1,060,408 New	1,060,408 $29.7 Million

Others Institutions Holding MRVI

# of Institutions

174

Shares Held

130M

Call Options Held

426K

Put Options Held

37.5K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $354M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Account